Pharmaceutical Business review

Stirling names new chief financial officer

Prior to joining Stirling, Kean has held positions as a tutor at the University of Technology in Sydney and as a senior researcher in fields including the Financial Reporting of Intangible Assets, Executive Remuneration, Voluntary Disclosure and Australian R & D.

Stirling said that Kean has commenced a review of the company’s operations and has already introduced a number of cost-cutting initiatives across all operations with overall financing and management accounting in process of being better positioned to accommodate the company’s forecast growth, sales and needs.